A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American …

CE Ndumele, IJ Neeland, KR Tuttle, SL Chow… - Circulation, 2023 - Am Heart Assoc
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors
such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led …

Dyslipidemia in chronic kidney disease: contemporary concepts and future therapeutic perspectives

P Theofilis, A Vordoni, M Koukoulaki… - American Journal of …, 2021 - karger.com
Background: Chronic kidney disease (CKD) is an increasingly prevalent disease state met
with great morbidity and mortality primarily resulting from the high incidence of adverse …

Anticoagulation in hemodialysis: a narrative review

SE Claudel, LA Miles, M Murea - Seminars in Dialysis, 2021 - Wiley Online Library
Systemic anticoagulation in maintenance hemodialysis (HD) has historically been
considered necessary to maintain the extracorporeal circuit (ECC) and preserve dialysis …

[HTML][HTML] Dyslipidemia in patients with chronic kidney disease: An updated overview

SH Suh, SW Kim - Diabetes & metabolism journal, 2023 - synapse.koreamed.org
Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the
recommendations for the treatment target of dyslipidemia in the general population are …

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases

M Lee, WJ Choi, Y Lee, K Lee, MW Park, JP Myong… - Scientific Reports, 2023 - nature.com
Statin therapy is essential for secondary prevention in patients with atherosclerotic
cardiovascular disease (ASCVD). However, the effects of statin therapy in patients receiving …

[HTML][HTML] Machine learning to identify dialysis patients at high death risk

O Akbilgic, Y Obi, PK Potukuchi, I Karabayir… - Kidney international …, 2019 - Elsevier
Introduction Given the high mortality rate within the first year of dialysis initiation, an accurate
estimation of postdialysis mortality could help patients and clinicians in decision making …

Association of statin therapy with major adverse cardiovascular and limb outcomes in patients with end-stage kidney disease and peripheral artery disease receiving …

HY Lo, YS Lin, DSH Lin, JK Lee, WJ Chen - JAMA Network Open, 2022 - jamanetwork.com
Importance Controversy exists regarding whether statin therapy has benefits for patients with
kidney failure, and the consequences of statin therapy for patients with kidney failure and …

Laxative use and risk of dyskalemia in patients with advanced CKD transitioning to dialysis

K Sumida, AA Dashputre, PK Potukuchi… - Journal of the …, 2021 - journals.lww.com
Background Patients with advanced CKD experience increased intestinal potassium
excretion. This compensatory mechanism may be enhanced by laxative use; however, little …

Laxative use in patients with advanced chronic kidney disease transitioning to dialysis

K Sumida, AA Dashputre, PK Potukuchi… - Nephrology Dialysis …, 2021 - academic.oup.com
Background Constipation is highly prevalent in patients with chronic kidney disease (CKD),
particularly among those with end-stage renal disease (ESRD), partly due to their dietary …

Clinical outcomes of warfarin initiation in advanced chronic kidney disease patients with incident atrial fibrillation

MA Agarwal, PK Potukuchi, K Sumida, A Naseer… - Clinical …, 2020 - jacc.org
Objectives The aim of this study was to examine the efficacy and safety of warfarin initiation
following the diagnosis of atrial fibrillation (AF) in patients with late-stage chronic kidney …